Similarly, apoa4 glycosylation (G-apoa4) is associated with coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM), and can induce atherosclerosis via nr4a3 [19]. Here, NR4A3 is linked to atherosclerosis.